MENU
+Compare
ATOS
Stock ticker: NASDAQ
AS OF
Jul 28, 04:43 PM (EDT)
Price
$0.81
Change
-$0.03 (-3.57%)
Capitalization
108.49M

ATOS Atossa Therapeutics Forecast, Technical & Fundamental Analysis

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology... Show more

ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATOS with price predictions
Jul 25, 2025

Aroon Indicator for ATOS shows an upward move is likely

ATOS's Aroon Indicator triggered a bullish signal on July 23, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 154 similar instances where the Aroon Indicator showed a similar pattern. In of the 154 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for ATOS crossed bullishly above the 50-day moving average on July 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATOS advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ATOS as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ATOS turned negative on July 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

ATOS moved below its 50-day moving average on July 24, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ATOS broke above its upper Bollinger Band on July 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.661) is normal, around the industry mean (18.019). P/E Ratio (0.000) is within average values for comparable stocks, (59.593). ATOS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (279.374).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ATOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATOS is expected to report earnings to rise 15.00% to -5 cents per share on August 18

Atossa Therapeutics ATOS Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Est.
$-0.06
Q2'24
Beat
by $0.01
The last earnings report on May 13 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 533.65K shares outstanding, the current market capitalization sits at 108.49M.
A.I. Advisor
published General Information

General Information

a manufacturer of products for breast cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
107 Spring Street
Phone
+1 206 588-0256
Employees
12
Web
https://www.atossatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DYLLF1.17N/A
+0.03%
Deep Yellow Ltd.
CYYNF0.08N/A
N/A
Cynata Therapeutics Ltd.
PSBAF0.13N/A
N/A
PT Sumber Alfaria Trijaya TBK
SFES0.68N/A
N/A
Safeguard Scientifics, Inc.
SOMLY9.10-0.10
-1.09%
Secom Co., Ltd.

ATOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with NRIX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
-2.55%
NRIX - ATOS
44%
Loosely correlated
-0.09%
PDSB - ATOS
44%
Loosely correlated
-2.48%
BEAM - ATOS
43%
Loosely correlated
+3.68%
ABOS - ATOS
43%
Loosely correlated
N/A
RXRX - ATOS
43%
Loosely correlated
+3.67%
More